The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Hedgehog Signaling: From Basic Biology to Cancer Therapy
Open accessAbstract
The Hedgehog (HH) signaling pathway was discovered originally as a key pathway in embryonic patterning and development. Since its discovery, it has become increasingly clear that the HH pathway also plays important roles in a multitude of cancers. Therefore, HH signaling has emerged as a therapeutic target of interest for cancer therapy. In this review, we provide a brief overview of HH signaling and the key molecular players involved and offer an up-to-date summary of our current knowledge of endogenous and exogenous small molecules that modulate HH signaling. We discuss experiences and lessons learned from the decades-long efforts toward the development of cancer therapies targeting the HH pathway. Challenges to develop next-generation cancer therapies are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–216 of 216
Wang, Y., Arvanites, A. C., Davidow, L. S., Blanchard, J., Lam, K., Yoo, J. W., Coy, S., Rubin, L. L., & McMahon, A. P. (2012) · ACS Chemical Biology · doi:10.1021/cb300028a · Cited by 45
Self-citationFerruzzi, P., Mennillo, F., Rosa, A. D., Giordano, C., Rossi, M., Benedetti, G., Magrini, R., Mohr, G. L. P., Miragliotta, V., Magnoni, L., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27349 · Cited by 45
Roudaut, H., Traiffort, É., Gorojankina, T., Vincent, L., Faure, H., Schoenfelder, A., Mann, A., Manetti, F., Solinas, A., Taddei, M., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069708 · Cited by 45
Targeting embryonic signaling pathways in cancer therapy
Harris, P. J., Speranza, G., & Ullmann, C. D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645808 · Cited by 42
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
Tibes, R., & Mesa, R. A. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-18 · Cited by 42
Monzó, M., Moreno, I., Artells, R., Ibeas, R., Navarro, A., Moreno, J., Hernandez, R., Granell, M., & Pie, J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.001 · Cited by 41
Patched1 and Patched2 inhibit Smoothened non-cell autonomously
Roberts, B., Casillas, C., Alfaro, A. C., Jägers, C., & Roelink, H. (2016) · eLife · doi:10.7554/elife.17634 · Cited by 38
Bifurcating action of Smoothened in Hedgehog signaling is mediated by Dlg5Preprint
Chong, Y. C., Mann, R. K., Zhao, C., Kato, M., & Beachy, P. A. (2015) · Genes & Development · doi:10.1101/gad.252676.114 · Cited by 35
Liu, Z., Li, T.-K., Reinhold, M. I., & Naski, M. C. (2012) · Oncogene · doi:10.1038/onc.2012.544 · Cited by 34
A Predictive Model of Bifunctional Transcription Factor Signaling during Embryonic Tissue Patterning
Junker, J. P., Peterson, K. A., Nishi, Y., Mao, J., McMahon, A. P., & van Oudenaarden, A. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.10.017 · Cited by 31
Self-citationGeoerger, B., Aerts, I., Casanova, M., Chisholm, J., Hargrave, D. R., Leary, S. E. S., Ashley, D. M., Bouffet, É., MacDonald, T. J., Hurh, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.9519 · Cited by 30
Rusert, J. M., Wu, X., Eberhart, C. G., Taylor, M. D., & Wechsler‐Reya, R. J. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.11.015 · Cited by 26
The loss of Hh responsiveness by a non-ciliary Gli2 variant
Liu, J., Zeng, H., & Liu, A. (2015) · Development · doi:10.1242/dev.119669 · Cited by 22
Peluso, M., Campbell, V. T., Harari, J. A., Tibbitts, T. T., Proctor, J., Whitebread, N., Conley, J. M., White, K., Kutok, J. L., Read, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090534 · Cited by 17
Chu, Q. S.-C., Mahipal, A., Schüler, M., de Braud, F., Dirix, L. Y., Rampersad, A., Zhou, J., Wu, Y., Kalambakas, S. A., & Wen, P. Y. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu331.5 · Cited by 13
Amakye, D. D., Robinson, D., Rose, K. L., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-4818 · Cited by 11
Cited by
Fibroblast growth factor receptors as treatment targets in clinical oncology
Katoh, M. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0115-y · Cited by 352
Regulation of Osteoblast Differentiation by Cytokine Networks
Amarasekara, D. S., Kim, S., & Rho, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062851 · Cited by 347
Wang, Y., Wang, J., Li, X., Xiong, X., Wang, J., Zhou, Z., Zhu, X., Gu, Y., Dominissini, D., He, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26718-6 · Cited by 265
Self-citationThe SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Lospinoso Severini, L., Ghirga, F., Bufalieri, F., Quaglio, D., Infante, P., & Di Marcotullio, L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1823967 · Cited by 61
Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT
Jiang, Y., Benz, T. L., & Long, S. B. (2021) · Science · doi:10.1126/science.abg4998 · Cited by 55
Metadata
- Authors
- Wu, F., Zhang, Y., Sun, B., McMahon, A. P., & Wang, Y.
- Venue
- Cell Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 24
- Issue
- 3
- Pages
- 252-280
- ISSN
- 2451-9448 (ISSN-L)
- 2451-9456
- OpenAlex
- W2594464065
- Cited by
- 302
- References
- 216
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.